Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5373491 | 0.94 | MCHR1 (0.40) | LMNAALDH1A1KDM4EMAPTNPSR1 | |
| SCHEMBL2686471 | 0.90 | ALDH1A1 (0.42) | LMNAALDH1A1KDM4EMAPTNPSR1 | |
| SCHEMBL1984241 | 0.88 | CYP1A2 (0.52) | LMNAALDH1A1KDM4EMAPTNPSR1 | |
| SCHEMBL29091824 | 0.85 | CYP1A2 (0.52) | LMNAALDH1A1KDM4EMAPTNPSR1 | |
| SCHEMBL5034227 | 0.82 | LMNA (0.44) | LMNAALDH1A1KDM4EMAPTNPSR1 | |
| SCHEMBL9420344 | 0.81 | SMN1; SMN2 (0.34) | LMNAKDM4EMAPTTDP1L3MBTL1 | |
| SCHEMBL8220033 | 0.78 | ALDH1A1 (0.44) | LMNAALDH1A1KDM4EMAPTNPSR1 | |
| SCHEMBL158540 | 0.78 | ALDH1A1 (0.41) | ALDH1A1KDM4EMAPTNPSR1L3MBTL1 | |
| SCHEMBL8223215 | 0.78 | CYP1A2 (0.47) | LMNAALDH1A1KDM4EMAPTNPSR1 | |
| SCHEMBL30957371 | 0.77 | ESR1 (0.49) | LMNAALDH1A1KDM4EMAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7186782-B2 | Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2007-03-06 | — | — | US | claimed |
| US-20060041079-A1 | Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer | TSRC CORPORATION | 2006-02-23 | — | — | US | claimed |
| US-20230087596-A1 | ESTER COMPOUND, METHOD FOR PRODUCING SAME, POLYMER, THERMOSETTING RESIN COMPOSITION AND CURED FILM | KYOEISHA CHEMICAL CO., LTD. (JP) | 2023-03-23 | — | — | US | disclosed |
| EP-4067395-A1 | ESTER COMPOUND, METHOD FOR PRODUCING SAME, POLYMER, THERMOSETTING RESIN COMPOSITION AND CURED FILM | Kyoeisha Chemical Co., Ltd. (JP) | 2022-10-05 | — | — | EP | disclosed |
| CN-114829415-A | Ester compound, method for producing same, polymer, thermosetting resin composition, and cured film | 共荣社化学株式会社 | 2022-07-29 | — | — | CN | disclosed |
| WO-2021132251-A1 | ESTER COMPOUND, METHOD FOR PRODUCING SAME, POLYMER, THERMOSETTING RESIN COMPOSITION AND CURED FILM | 共栄社化学株式会社 | 2021-07-01 | — | — | WO | disclosed |
| WO-2021131030-A1 | ESTER COMPOUND, PRODUCTION METHOD THEREFOR, POLYMER, THERMALLY CURABLE RESIN COMPOSITION, AND CURED FILM | 共栄社化学株式会社 | 2021-07-01 | — | — | WO | disclosed |
| US-7466893-B2 | Curable resin composition for light guide formation, curable dry film for light guide formation, cured resin and light guide | KANSAI PAINT CO., LTD. (JP) | 2008-12-16 | — | — | US | disclosed |
| EP-1999167-A2 | ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR | Novolen Technology Holdings, C.V. (NL) | 2008-12-10 | — | — | EP | disclosed |
| US-20080226245-A1 | Epoxy resin that is modified with a tetraalkoxysilane or alkyltrialkoxysilane to form a hydrolyzable resin and another resin that is reactive with an epoxy group, such as an acrylic acid-acrylate copolymer; optical waveguides with high heat resistance, excellent mechanical strength and transparency | KANSAI PAINT CO., LTD. (JP) | 2008-09-18 | — | — | US | disclosed |
| WO-2007106348-A2 | ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR | NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) | 2007-09-20 | — | — | WO | disclosed |
| US-20070213204-A1 | Ziegler-Natta catalyst with in situ-generated donor | NOVOLEN TECHNOLOGY HOLDINGS C.V. | 2007-09-13 | — | — | US | disclosed |
| US-7186782-B2 | Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2007-03-06 | — | — | US | disclosed |
| US-20060041079-A1 | Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer | TSRC CORPORATION | 2006-02-23 | — | — | US | disclosed |
| US-5731037-A | CONTROLLING SURFACE MOISTURE OF BUILDING MATERIAL | KANSAI PAINT CO., LTD. (JP) | 1998-03-24 | — | — | US | disclosed |
| EP-0236674-B1 | Improved mineral filled rubber composites | DOW CORNING (US) | 1994-02-16 | — | — | EP | disclosed |
| US-4965312-A | Nonaqueous vehicle composition for coating materials | KANSAI PAINT COMPANY, LIMITED (JP) | 1990-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230087596-A1 | ESTER COMPOUND, METHOD FOR PRODUCING SAME, POLYMER, THERMOSETTING RESIN COMPOSITION AND CURED FILM | RER1, EMG1, SETDB1 | LMNA 2861/4885ALDH1A1 1084/4885KDM4E 222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.